Another company, Saluda Medical, already has FDA approval ... they expect to “revolutionize” the market. The use of ...
Saluda Medical has completed a $100m financing ... The platform claims to operate by delivering spinal cord stimulation (SCS) therapy that senses and measures neural activation, with an aim ...
MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Saluda Medical ... of objective neurophysiological measurements in spinal cord stimulation (SCS) with evoked compound action potential (ECAP) dose ...